Skip to content
Menu

Member

2 posts

Posts (2)

Member HTBX 6 years ago #2

Great to see the bonus of the CoVID pipeline. Else the platform benefit of immune-therapy and cell therapy in the companies pipeline is already leveraged by many startups for cancer treatment. All diseases in the world could be treated by modulating the immune system and the technology development in this area is certainly promising for all the diseases in the world, including Cancer or CoVID.